vs

Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and CULLEN/FROST BANKERS, INC. (CFR). Click either name above to swap in a different company.

Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $580.9M, roughly 1.4× CULLEN/FROST BANKERS, INC.). CULLEN/FROST BANKERS, INC. runs the higher net margin — 28.6% vs 0.5%, a 28.1% gap on every dollar of revenue. On growth, CULLEN/FROST BANKERS, INC. posted the faster year-over-year revenue change (8.3% vs 7.5%). Over the past eight quarters, CULLEN/FROST BANKERS, INC.'s revenue compounded faster (7.6% CAGR vs 2.0%).

Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.

Frost Bank is an American bank based in San Antonio that is chartered in Texas, with 200 branches and 1,750 automated teller machines in the state. It is the primary subsidiary of Cullen/Frost Bankers, Inc., a bank holding company. It is one of the 60 largest banks of the country by total assets.

ACHC vs CFR — Head-to-Head

Bigger by revenue
ACHC
ACHC
1.4× larger
ACHC
$829.0M
$580.9M
CFR
Growing faster (revenue YoY)
CFR
CFR
+0.8% gap
CFR
8.3%
7.5%
ACHC
Higher net margin
CFR
CFR
28.1% more per $
CFR
28.6%
0.5%
ACHC
Faster 2-yr revenue CAGR
CFR
CFR
Annualised
CFR
7.6%
2.0%
ACHC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACHC
ACHC
CFR
CFR
Revenue
$829.0M
$580.9M
Net Profit
$4.5M
$166.3M
Gross Margin
Operating Margin
34.1%
Net Margin
0.5%
28.6%
Revenue YoY
7.5%
8.3%
Net Profit YoY
-50.8%
7.4%
EPS (diluted)
$0.05
$2.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACHC
ACHC
CFR
CFR
Q1 26
$829.0M
Q4 25
$821.5M
$580.9M
Q3 25
$851.6M
$567.3M
Q2 25
$869.2M
$546.9M
Q1 25
$770.5M
$540.2M
Q4 24
$774.2M
$536.3M
Q3 24
$815.6M
$518.0M
Q2 24
$796.0M
$507.9M
Net Profit
ACHC
ACHC
CFR
CFR
Q1 26
$4.5M
Q4 25
$-1.2B
$166.3M
Q3 25
$36.2M
$174.4M
Q2 25
$30.1M
$157.0M
Q1 25
$8.4M
$150.9M
Q4 24
$32.6M
$154.9M
Q3 24
$68.1M
$146.5M
Q2 24
$78.5M
$145.5M
Operating Margin
ACHC
ACHC
CFR
CFR
Q1 26
Q4 25
-142.4%
34.1%
Q3 25
4.7%
36.7%
Q2 25
5.8%
34.1%
Q1 25
1.7%
33.2%
Q4 24
4.9%
34.3%
Q3 24
12.1%
33.8%
Q2 24
13.4%
34.5%
Net Margin
ACHC
ACHC
CFR
CFR
Q1 26
0.5%
Q4 25
-143.3%
28.6%
Q3 25
4.3%
30.7%
Q2 25
3.5%
28.7%
Q1 25
1.1%
27.9%
Q4 24
4.2%
28.9%
Q3 24
8.4%
28.3%
Q2 24
9.9%
28.6%
EPS (diluted)
ACHC
ACHC
CFR
CFR
Q1 26
$0.05
Q4 25
$-12.98
$2.56
Q3 25
$0.40
$2.67
Q2 25
$0.33
$2.39
Q1 25
$0.09
$2.30
Q4 24
$0.36
$2.36
Q3 24
$0.74
$2.24
Q2 24
$0.85
$2.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACHC
ACHC
CFR
CFR
Cash + ST InvestmentsLiquidity on hand
$158.5M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$2.0B
$4.6B
Total Assets
$5.5B
$53.0B
Debt / EquityLower = less leverage
1.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACHC
ACHC
CFR
CFR
Q1 26
$158.5M
Q4 25
$133.2M
Q3 25
$118.7M
Q2 25
$131.4M
Q1 25
$91.2M
Q4 24
$76.3M
Q3 24
$82.1M
Q2 24
$77.2M
Total Debt
ACHC
ACHC
CFR
CFR
Q1 26
$2.5B
Q4 25
$2.5B
Q3 25
$2.3B
Q2 25
$2.3B
Q1 25
$2.2B
Q4 24
$2.0B
Q3 24
$1.9B
Q2 24
$1.8B
Stockholders' Equity
ACHC
ACHC
CFR
CFR
Q1 26
$2.0B
Q4 25
$1.9B
$4.6B
Q3 25
$3.1B
$4.5B
Q2 25
$3.1B
$4.2B
Q1 25
$3.0B
$4.1B
Q4 24
$3.1B
$3.9B
Q3 24
$3.0B
$4.1B
Q2 24
$3.0B
$3.7B
Total Assets
ACHC
ACHC
CFR
CFR
Q1 26
$5.5B
Q4 25
$5.5B
$53.0B
Q3 25
$6.4B
$52.5B
Q2 25
$6.3B
$51.4B
Q1 25
$6.1B
$52.0B
Q4 24
$6.0B
$52.5B
Q3 24
$5.9B
$51.0B
Q2 24
$5.7B
$48.8B
Debt / Equity
ACHC
ACHC
CFR
CFR
Q1 26
1.29×
Q4 25
1.28×
Q3 25
0.74×
Q2 25
0.74×
Q1 25
0.72×
Q4 24
0.64×
Q3 24
0.62×
Q2 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACHC
ACHC
CFR
CFR
Operating Cash FlowLast quarter
$61.5M
$274.0M
Free Cash FlowOCF − Capex
$127.3M
FCF MarginFCF / Revenue
21.9%
Capex IntensityCapex / Revenue
25.2%
Cash ConversionOCF / Net Profit
13.78×
1.65×
TTM Free Cash FlowTrailing 4 quarters
$116.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACHC
ACHC
CFR
CFR
Q1 26
$61.5M
Q4 25
$-86.3M
$274.0M
Q3 25
$73.2M
$248.6M
Q2 25
$133.5M
$140.8M
Q1 25
$11.5M
$-296.1M
Q4 24
$116.7M
$989.5M
Q3 24
$163.1M
$307.2M
Q2 24
$171.1M
$129.6M
Free Cash Flow
ACHC
ACHC
CFR
CFR
Q1 26
Q4 25
$-179.5M
$127.3M
Q3 25
$-63.0M
$211.7M
Q2 25
$-34.2M
$114.5M
Q1 25
$-163.2M
$-337.1M
Q4 24
$-86.8M
$861.8M
Q3 24
$-27.1M
$281.9M
Q2 24
$16.9M
$103.0M
FCF Margin
ACHC
ACHC
CFR
CFR
Q1 26
Q4 25
-21.8%
21.9%
Q3 25
-7.4%
37.3%
Q2 25
-3.9%
20.9%
Q1 25
-21.2%
-62.4%
Q4 24
-11.2%
160.7%
Q3 24
-3.3%
54.4%
Q2 24
2.1%
20.3%
Capex Intensity
ACHC
ACHC
CFR
CFR
Q1 26
Q4 25
11.3%
25.2%
Q3 25
16.0%
6.5%
Q2 25
19.3%
4.8%
Q1 25
22.7%
7.6%
Q4 24
26.3%
23.8%
Q3 24
23.3%
4.9%
Q2 24
19.4%
5.2%
Cash Conversion
ACHC
ACHC
CFR
CFR
Q1 26
13.78×
Q4 25
1.65×
Q3 25
2.02×
1.43×
Q2 25
4.43×
0.90×
Q1 25
1.37×
-1.96×
Q4 24
3.58×
6.39×
Q3 24
2.39×
2.10×
Q2 24
2.18×
0.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACHC
ACHC

Acute Inpatient Psychiatric Facilities$471.0M57%
Other$140.0M17%
Specialty Treatment Facilities$128.0M15%
Residential Treatment Facilities$90.0M11%

CFR
CFR

Segment breakdown not available.

Related Comparisons